BIOFLOW-III VIP Russia Registry Orsiro Stent System

NCT02247492 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2018-07-23

No results posted yet for this study

Summary

Clinical evaluation of the Orsiro LESS in subjects requiring coronary revascularization with Drug Eluting Stents (DES). Along with it, an explanatory (hypothesis-finding) problem will be investigated, whether the patient's body inflammation status correlates with the clinical outcome.

Conditions

  • Coronary Artery Diseases

Sponsors & Collaborators

  • Biotronik Russia

    lead INDUSTRY

Principal Investigators

  • Evgeny Kretov, Dr. · Novosibirsk Research Institute for Circulation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-14
Primary Completion
2019-04-30
Completion
2021-05-31

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02247492 on ClinicalTrials.gov